170 related articles for article (PubMed ID: 27852047)
21. Gene expression profiles in esophageal adenocarcinoma predict survival after resection.
Pennathur A; Xi L; Litle VR; Gooding WE; Krasinskas A; Landreneau RJ; Godfrey TE; Luketich JD
J Thorac Cardiovasc Surg; 2013 Feb; 145(2):505-12; discussion 512-3. PubMed ID: 23321130
[TBL] [Abstract][Full Text] [Related]
22. The prognostic and chemotherapeutic value of miR-296 in esophageal squamous cell carcinoma.
Hong L; Han Y; Zhang H; Li M; Gong T; Sun L; Wu K; Zhao Q; Fan D
Ann Surg; 2010 Jun; 251(6):1056-63. PubMed ID: 20485139
[TBL] [Abstract][Full Text] [Related]
23. Clinical Significance of Sentinel Node Positivity in Patients with Superficial Esophageal Cancer.
Takeuchi H; Kawakubo H; Nakamura R; Fukuda K; Takahashi T; Wada N; Kitagawa Y
World J Surg; 2015 Dec; 39(12):2941-7. PubMed ID: 26296842
[TBL] [Abstract][Full Text] [Related]
24. MiR-142-3p as a potential prognostic biomarker for esophageal squamous cell carcinoma.
Lin RJ; Xiao DW; Liao LD; Chen T; Xie ZF; Huang WZ; Wang WS; Jiang TF; Wu BL; Li EM; Xu LY
J Surg Oncol; 2012 Feb; 105(2):175-82. PubMed ID: 21882196
[TBL] [Abstract][Full Text] [Related]
25. Expression of lysyl oxidase is correlated with lymph node metastasis and poor prognosis in esophageal squamous cell carcinoma.
Sakai M; Kato H; Sano A; Tanaka N; Inose T; Kimura H; Sohda M; Nakajima M; Kuwano H
Ann Surg Oncol; 2009 Sep; 16(9):2494-501. PubMed ID: 19526206
[TBL] [Abstract][Full Text] [Related]
26. Targeted next-generation sequencing of commonly mutated genes in esophageal adenocarcinoma patients with long-term survival.
Visser E; Franken IA; Brosens LAA; de Leng WWJ; Strengman E; Offerhaus JA; Ruurda JP; van Hillegersberg R
Dis Esophagus; 2017 Sep; 30(9):1-8. PubMed ID: 28859360
[TBL] [Abstract][Full Text] [Related]
27. New therapeutic strategies for squamous cell cancer and adenocarcinoma.
Wijnhoven BPL; Toxopeus ELA; Vallböhmer D; Knoefel WT; Krasna MJ; Perez K; van Rossum PSN; Ruurda JP; van Hillegersberg R; Schiesser M; Schneider P; Felix VN
Ann N Y Acad Sci; 2013 Oct; 1300():213-225. PubMed ID: 24117644
[TBL] [Abstract][Full Text] [Related]
28. Gene expression profiling of the response of esophageal carcinoma cells to cisplatin.
Takashima N; Ishiguro H; Kuwabara Y; Kimura M; Mitui A; Mori Y; Mori R; Tomoda K; Hamaguchi M; Ogawa R; Katada T; Harada K; Fujii Y
Dis Esophagus; 2008; 21(3):230-5. PubMed ID: 18430104
[TBL] [Abstract][Full Text] [Related]
29. Loss of CRNN expression is associated with advanced tumor stage and poor survival in patients with esophageal squamous cell carcinoma.
Hsu PK; Kao HL; Chen HY; Yen CC; Wu YC; Hsu WH; Chou TY
J Thorac Cardiovasc Surg; 2014 May; 147(5):1612-1618.e4. PubMed ID: 24263008
[TBL] [Abstract][Full Text] [Related]
30. MiR-205 functions as a tumor suppressor in adenocarcinoma and an oncogene in squamous cell carcinoma of esophagus.
Hezova R; Kovarikova A; Srovnal J; Zemanova M; Harustiak T; Ehrmann J; Hajduch M; Sachlova M; Svoboda M; Slaby O
Tumour Biol; 2016 Jun; 37(6):8007-18. PubMed ID: 26711784
[TBL] [Abstract][Full Text] [Related]
31. Transcriptome profiling of lncRNA and co-expression networks in esophageal squamous cell carcinoma by RNA sequencing.
Li Y; Shi X; Yang W; Lu Z; Wang P; Chen Z; He J
Tumour Biol; 2016 Oct; 37(10):13091-13100. PubMed ID: 27449043
[TBL] [Abstract][Full Text] [Related]
32. Prognostic factors and family history for survival of esophageal squamous cell carcinoma patients after surgery.
Yuequan J; Shifeng C; Bing Z
Ann Thorac Surg; 2010 Sep; 90(3):908-13. PubMed ID: 20732516
[TBL] [Abstract][Full Text] [Related]
33. Sphingosine-1-phosphate/sphingosine kinase 1-dependent lymph node metastasis in esophageal squamous cell carcinoma.
Kawakita Y; Motoyama S; Sato Y; Koyota S; Wakita A; Liu J; Saito H; Minamiya Y
Surg Today; 2017 Nov; 47(11):1312-1320. PubMed ID: 28364399
[TBL] [Abstract][Full Text] [Related]
34. Genome-wide profiling of DNA methylation and gene expression in esophageal squamous cell carcinoma.
Chen C; Peng H; Huang X; Zhao M; Li Z; Yin N; Wang X; Yu F; Yin B; Yuan Y; Lu Q
Oncotarget; 2016 Jan; 7(4):4507-21. PubMed ID: 26683359
[TBL] [Abstract][Full Text] [Related]
35. Biomarkers of response to preoperative chemoradiation in esophageal cancers.
Luthra R; Luthra MG; Izzo J; Wu TT; Lopez-Alvarez E; Malhotra U; Choi IS; Zhang L; Ajani JA
Semin Oncol; 2006 Dec; 33(6 Suppl 11):S2-5. PubMed ID: 17178277
[TBL] [Abstract][Full Text] [Related]
36. Non-overlapping and non-cell-type-specific gene expression signatures predict lung cancer survival.
Sun Z; Wigle DA; Yang P
J Clin Oncol; 2008 Feb; 26(6):877-83. PubMed ID: 18281660
[TBL] [Abstract][Full Text] [Related]
37. Clinicopathological and prognostic significance of mTOR and phosphorylated mTOR expression in patients with esophageal squamous cell carcinoma: a systematic review and meta-analysis.
Li S; Wang Z; Huang J; Cheng S; Du H; Che G; Peng Y
BMC Cancer; 2016 Nov; 16(1):877. PubMed ID: 27835987
[TBL] [Abstract][Full Text] [Related]
38. Deregulated p21(WAF1) overexpression impacts survival of surgically resected esophageal squamous cell carcinoma patients.
Goan YG; Hsu HK; Chang HC; Chou YP; Chiang KH; Cheng JT
Ann Thorac Surg; 2005 Sep; 80(3):1007-16. PubMed ID: 16122475
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of miR-21 and miR-375 as prognostic biomarkers in esophageal cancer.
Winther M; Alsner J; Tramm T; Baeksgaard L; Holtved E; Nordsmark M
Acta Oncol; 2015; 54(9):1582-91. PubMed ID: 26481465
[TBL] [Abstract][Full Text] [Related]
40. Concordance of HER2 status in primary tumour and lymph node metastases in patients with esophageal carcinoma.
König AM; Reeh M; Dancau AM; Rathjens M; Gros S; Uzunoglu FG; Bockhorn M; Simon R; Sauter G; Marx A; Izbicki JR
Anticancer Res; 2013 Nov; 33(11):4975-82. PubMed ID: 24222138
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]